WELLINGTON MANAGEMENT GROUP LLP - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 46 filers reported holding SIGILON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$6,660,000
-25.3%
620,713
+55.6%
0.00%
-50.0%
Q1 2021$8,919,000
-62.4%
399,038
-19.2%
0.00%
-50.0%
Q4 2020$23,715,000493,7630.00%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 740,740$35,578,00013.90%
Flagship Pioneering Inc. 10,370,369$498,089,0009.07%
Monashee Investment Management LLC 561,628$26,975,0003.56%
SPHERA FUNDS MANAGEMENT LTD. 567,460$26,061,0002.31%
Avidity Partners Management LP 688,000$33,045,0001.07%
SECTORAL ASSET MANAGEMENT INC 225,000$10,807,0000.76%
Artal Group S.A. 276,000$13,256,0000.28%
GILDER GAGNON HOWE & CO LLC 662,227$31,807,0000.16%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$71,333,0000.11%
Perceptive Advisors 125,000$6,004,0000.06%
View complete list of SIGILON THERAPEUTICS INC shareholders